Polymerase chain reaction (PCR) is a technology that has opened up new vistas for advances in life sciences research and molecular diagnostics due to its attributes, such as detection and quantification of DNA and RNA genetic materials.
This report contains market size and forecasts of Clinical Diagnostics PCR in Global, including the following market information:
Global Clinical Diagnostics PCR Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Clinical Diagnostics PCR market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Infectious Disease Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Clinical Diagnostics PCR include Abbott Laboratories, Agilent Technologies Inc., Abbott, Asuragen, Inc., Danaher, Biocartis Group Nv, Biomérieux, Bio-Rad Laboratories, Inc. and Genmark Diagnostics, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Clinical Diagnostics PCR companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Clinical Diagnostics PCR Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Clinical Diagnostics PCR Market Segment Percentages, by Type, 2021 (%)
Infectious Disease
Cancer
Cardiovascular
Genetic
Others
Global Clinical Diagnostics PCR Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Clinical Diagnostics PCR Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Clinical Diagnostics PCR Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Clinical Diagnostics PCR Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Clinical Diagnostics PCR revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Clinical Diagnostics PCR revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Agilent Technologies Inc.
Abbott
Asuragen, Inc.
Danaher
Biocartis Group Nv
Biomérieux
Bio-Rad Laboratories, Inc.
Genmark Diagnostics, Inc.
Hologic, Inc.
Luminex Corporation
Meridian Bioscience, Inc.
Qiagen N.V.
Quantumdx Group
Quidel, Inc.
Roche